Ampio Pharmaceuticals (AMPE) Stock Chart & Stock Price History $0.12 +0.11 (+4,200.00%) As of 06/13/2025 01:11 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Ampio Pharmaceuticals Stock Price Performance The Ampio Pharmaceuticals (AMPE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 10.69%, with a year-to-date return of 4,365.38%. In the past month, the stock has increased 3,770.00%, reflecting recent market activity. As of the latest close, Ampio Pharmaceuticals traded at $0.12 with a market cap of $132 thousand and volume of 668 shares. Five years ago, the stock traded at a split-adjusted price of $9.40, representing a 98.77% decrease over that period. At the time, it had a market cap of $77.51 million and a volume of 64,390 shares. Receive AMPE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-11.00%1 Month Performance+3,770.00%3 Month Performance+5,428.57%Year-To-Date Performance+4,365.38%1 Year Performance-10.69%5 Year Performance-98.77% AMPE Stock Chart for Saturday, June, 14, 2025 AMPE Chart by TradingView Ampio Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$0.00$0.12+4,200.00%$0.12$0.12668 shs$132,000.0006/12/2025$0.00$0.00$0.00$0.00140 shs$3,000.0006/11/2025$0.13$0.00-97.93%$0.00$0.00140 shs$3,000.0006/10/2025$0.13$0.13$0.13$0.1372 shs$148,000.0006/09/2025$0.13$0.13$0.13$0.1366 shs$148,000.0006/06/2025$0.13$0.13$0.13$0.121,590 shs$148,000.0006/05/2025$0.00$0.13+4,250.00%$0.13$0.121,590 shs$148,000.0006/04/2025$0.00$0.00$0.00$0.0065 shs$3,000.0006/03/2025$0.00$0.00$0.00$0.0050 shs$3,000.0006/02/2025$0.00$0.00$0.00$0.001 shs$3,000.00 Get the Latest News and Ratings for AMPE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$0.00$0.00$0.00$0.001 shs$3,000.0005/29/2025$0.00$0.00$0.00$0.001 shs$3,000.0005/28/2025$0.00$0.00$0.00$0.008 shs$3,000.0005/27/2025$0.00$0.00$0.00$0.006 shs$3,000.0005/26/2025$0.00$0.00$0.00$0.006 shs$3,000.0005/23/2025$0.00$0.00$0.00$0.00105 shs$3,000.0005/22/2025$0.00$0.00$0.00$0.00105 shs$3,000.0005/21/2025$0.00$0.00-3.23%$0.00$0.00147 shs$3,000.0005/20/2025$0.00$0.00$0.00$0.00335 shs$4,000.0005/19/2025$0.00$0.00+3.33%$0.00$0.00335 shs$4,000.0005/16/2025$0.00$0.00$0.00$0.0033 shs$3,000.0005/15/2025$0.00$0.00$0.00$0.00480 shs$3,000.0005/14/2025$0.00$0.00$0.00$0.00480 shs$3,000.0005/13/2025$0.00$0.00$0.00$0.00110 shs$3,000.00 Related Companies Biophytis Stock Chart NuCana Stock Chart MyMD Pharmaceuticals Stock Chart Kiromic BioPharma Stock Chart Virpax Pharmaceuticals Stock Chart Capstone Stock Chart TFF Pharmaceuticals Stock Chart Bon Natural Life Stock Chart TC Biopharm Stock Chart Vincerx Pharma Stock Chart Receive AMPE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:AMPE) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ampio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ampio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
